Question, in order to manage my expectations. This recent study is simply to gather covid biomarkers, obtained in a clinical environment. This dataset will then be used to develop the algorythm first! Correct?
Then what?? Does RAP need to run another clinical trial to proof safety in use of the product? This will take months and I feel RAP missed the train. Also since covid symptoms might change with new variants?
COVID-19 Instant Screening test, page-443
-
- There are more pages in this discussion • 579 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| RAP (ASX) Chart |
Day chart unavailable